Validation of anti-COVID-19 drugs using the diagnostic tools of the future
Find out how LC-MS technology is being used to quantify the experimental drug remdesivir
Find out how LC-MS technology is being used to quantify the experimental drug remdesivir
Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy
AI applied to tumor microscopy images detects patterns of 167 different mutations and predicts patient survival in 28 cancer types
Omics expert, Professor Gary Patti, shares his thoughts on the current trends in metabolomics and discusses how multiple omics datasets can enhance our understanding of biology and disease
Ed Siegwart explains how serial passage is being used to assess the resistance development of C. difficile to new drug combinations
Watch our curated collection of The Scientists' Channel interviews from some of the experts joining us at this year's summit
Creoptix’s WAVEsystem offers a breakthrough level of kinetics analysis and will now form a critical part of Malvern Panalytical’s expanding drug discovery solutions
Join us online to discover the latest developments in clinical laboratory science, from new diagnostic approaches to cutting-edge point-of-care technologies, improving patient care, and much more
Watch this on-demand webinar to learn how metal interactions with oligonucleotides impact LC-MS performance, sensitivity and reproducibility
AutoDG™ Instrument for automated droplet generation of up to 96 samples, for use with the QX200™/QX100™ Droplet Digital™ PCR Systems
Alpha is a bead-based, no-wash luminescent technology. When Alpha Donor and Acceptor beads are brought together through binding to target, a cascade of chemical reactions is set in motion, creating an amplified signal. These versatile beads are conjugated with various biomolecules that enable detection of unique biological events, offering maximum flexibility.